tiprankstipranks
Trending News
More News >
Boston Scientific (CH:BSX)
:BSX
Switzerland Market
Advertisement

Boston Scientific (BSX) Earnings Dates, Call Summary & Reports

Compare
0 Followers

Earnings Data

Report Date
Feb 04, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.62
Last Year’s EPS
0.56
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 22, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a strong positive outlook with significant sales and EPS growth, driven by the success of key products like WATCHMAN and EP. However, there were challenges in the EMEA region and some product lines, particularly due to operational disruptions and market-specific headwinds.
Company Guidance
In the Boston Scientific third quarter 2025 earnings call, the company reported robust financial performance, with total operational sales growing 19% and organic sales increasing by 15%, surpassing the guidance range of 12% to 14%. Adjusted EPS for the quarter was $0.75, a 19% increase, exceeding the guidance range of $0.70 to $0.72. The adjusted operating margin was 28%, and the company raised its full-year adjusted EPS guidance to $3.02-$3.04, representing growth of 20% to 21%. Looking ahead, Boston Scientific is guiding for 11% to 13% organic growth in Q4 2025, which would lift full-year 2025 guidance to approximately 15.5%. Region-wise, the U.S. saw a 27% operational growth, while Asia Pac grew 17%, led by strong performances in Japan and China. However, Europe, Middle East, and Africa (EMEA) declined by 2% due to specific headwinds, including the discontinuation of the ACURATE valve and ERP system upgrades, resulting in a $30 million backorder. Despite these challenges, the company anticipates improved backorder management in Q4.
Exceeding Revenue and EPS Expectations
Total company operational sales grew 19% and organic sales grew 15%, exceeding guidance of 12% to 14%. Q3 adjusted EPS of $0.75 grew 19%, exceeding guidance range of $0.70 to $0.72.
Strong Regional Growth
U.S. operational growth was 27%, driven by Cardiovascular, Endoscopy, and Neuromodulation. Asia Pac grew 17% operationally, led by Japan and China.
WATCHMAN and EP Success
WATCHMAN grew 35% this quarter with over 600,000 patients treated. EP sales grew 63%, with strong adoption of FARAPULSE technology.
Improved Full Year Guidance
Raised full year '25 adjusted EPS guidance to $3.02 to $3.04, representing growth of 20% to 21%. Full year organic revenue growth guidance increased to approximately 15.5%.

Boston Scientific (CH:BSX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:BSX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 04, 2026
2025 (Q4)
0.62 / -
0.557
Oct 22, 2025
2025 (Q3)
0.57 / 0.60
0.50119.05% (+0.10)
Jul 23, 2025
2025 (Q2)
0.58 / 0.60
0.49320.97% (+0.10)
Apr 23, 2025
2025 (Q1)
0.54 / 0.60
0.44633.93% (+0.15)
Feb 05, 2025
2024 (Q4)
0.52 / 0.56
0.43827.27% (+0.12)
Oct 23, 2024
2024 (Q3)
0.47 / 0.50
0.39826.00% (+0.10)
Jul 24, 2024
2024 (Q2)
0.46 / 0.49
0.42216.98% (+0.07)
Apr 24, 2024
2024 (Q1)
0.41 / 0.45
0.37419.15% (+0.07)
Jan 31, 2024
2023 (Q4)
0.41 / 0.44
0.35822.22% (+0.08)
Oct 26, 2023
2023 (Q3)
0.38 / 0.40
0.34216.28% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does Boston Scientific (CH:BSX) report earnings?
Boston Scientific (CH:BSX) is schdueled to report earning on Feb 04, 2026, Before Open (Confirmed).
    What is Boston Scientific (CH:BSX) earnings time?
    Boston Scientific (CH:BSX) earnings time is at Feb 04, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Boston Scientific stock?
          The P/E ratio of Boston Scientific is N/A.
            What is CH:BSX EPS forecast?
            CH:BSX EPS forecast for the fiscal quarter 2025 (Q4) is 0.62.

              Boston Scientific (CH:BSX) Earnings News

              Boston Scientific (NYSE:BSX) Surges on Stellar Q4 Results
              Premium
              Market News
              Boston Scientific (NYSE:BSX) Surges on Stellar Q4 Results
              2y ago
              Boston Scientific Gains on Q1 Beat
              Premium
              Market News
              Boston Scientific Gains on Q1 Beat
              3y ago
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis